SNX5542, an oral Hsp90 inhibitor, causes Her2 degradation and inhibition of tumor growth in models of Her2 amplified breast cancer Meeting Abstract
| Authors: | Chandarlapaty, S.; Ye, Q.; Huang, K.; Fadden, P.; Rosen, N.; Solit, D. |
| Abstract Title: | SNX5542, an oral Hsp90 inhibitor, causes Her2 degradation and inhibition of tumor growth in models of Her2 amplified breast cancer |
| Meeting Title: | 18th EORTC-NCI-AACR Symposium on Molecular Targets and Cancer Therapeutics |
| Journal Title: | EJC Supplements |
| Volume: | 4 |
| Issue: | 12 |
| Meeting Dates: | 2006 Nov 7-10 |
| Meeting Location: | Prague, Czech Republic |
| ISSN: | 1359-6349 |
| Publisher: | Pergamon-Elsevier Science Ltd |
| Date Published: | 2006-11-01 |
| Start Page: | 165 |
| Language: | English |
| ACCESSION: | WOS:000242688500539 |
| DOI: | 10.1016/s1359-6349(06)70549-3 |
| PROVIDER: | wos |
| Notes: | --- - Meeting Abstract: 544 - "Source: Wos" |
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
-
425Rosen -
779Solit -
277Chandarlapaty -
25Ye
Related MSK Work